Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonvalvular Atrial Fibrillation”

62 trials

Showing 20 of 62 results

Not applicableStudy completedNCT02447341
What this trial is testing

Profile and Antithrombotic Management of Patients With NVAF Attending Internal Medicine Departments in Spain (PERFILAR Study)

Who this might be right for
Anticoagulation, Blood Thinners , Atrial Fibrillation, Bleeding, Stroke
Bristol-Myers Squibb 987
Not applicableStudy completedNCT04047654
What this trial is testing

Efficacy and Safety of Oral Anticoagulants Among Thai Octogenarians With Nonvalvular Atrial Fibrillation

Who this might be right for
StrokeAtrial Fibrillation
Mahidol University 327
Not applicableLooking for participantsNCT07815119
What this trial is testing

TEE-Guided Versus CCTA-Guided Preprocedural Imaging for Left Atrial Appendage Closure

Who this might be right for
Nonvalvular Atrial Fibrillation
Shanghai Zhongshan Hospital 590
Not applicableStudy completedNCT02007655
What this trial is testing

Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation

Who this might be right for
NonValvular Atrial Fibrillation
Bristol-Myers Squibb 6,372
Large-scale testing (Phase 3)Study completedNCT01674647
What this trial is testing

Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion

Who this might be right for
Atrial Fibrillation
Bayer 1,504
Not applicableStudy completedNCT02975453
What this trial is testing

Study of Major Cardiovascular Events in Patients With Nonvalvular Atrial Fibrillation Treated With Rivaroxaban

Who this might be right for
Atrial Fibrillation
Bayer 1,481
Not applicableUnknownNCT05911685
What this trial is testing

Evaluation of the Safety and Efficacy of a Novel SeaLA™ Left Atrial Appendage Occluder

Who this might be right for
Atrial Fibrillation
Hangzhou Dinova EP Technology Co., Ltd 163
Not applicableStudy completedNCT02769078
What this trial is testing

Replication Of An Early Evaluation Of 30-Day Readmissions Among Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran, Rivaroxaban, Apixaban, or Warfarin In The U.S

Who this might be right for
Atrial Fibrillation
Bristol-Myers Squibb 14,201
Large-scale testing (Phase 3)Study completedNCT02072434
What this trial is testing

Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF)

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo 2,199
Not applicableStudy completedNCT04509193
What this trial is testing

A Study Using Electronic Health Information to Learn About Rivaroxaban Compared to Warfarin in Participants With Non-valvular Atrial Fibrillation (NVAF) and Diabetes

Who this might be right for
Atrial Fibrillation
Bayer 116,049
Not applicableUnknownNCT05731882
What this trial is testing

First in Man Study of Left Atrial Appendage Pulsed Field Ablation Occluder

Who this might be right for
Nonvalvular Atrial Fibrillation
Hangzhou Dinova EP Technology Co., Ltd 10
Testing effectiveness (Phase 2)Study completedNCT00684307
What this trial is testing

Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation

Who this might be right for
Nonvalvular Atrial Fibrillation
AstraZeneca 1,084
Not applicableStudy completedNCT02964949
What this trial is testing

Comparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical Outcomes

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo 607
Not applicableStudy completedNCT02944019
What this trial is testing

Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo 13,980
Large-scale testing (Phase 3)Study completedNCT00171769
What this trial is testing

Atrial Fibrillation Feasibility Certoparin Trial - AFFECT

Who this might be right for
Persistent Nonvalvular Atrial Fibrillation
Novartis 200
Not applicableStudy completedNCT01928979
What this trial is testing

Retrospective Registry Providing Baseline Data on the Outcome of Left Atrial (LA) or LA Appendage (LAA) Thrombus in Patients With Nonvalvular Atrial Fibrillation (AF) or Atrial Flutter After Standard of Care (SoC) Anticoagulant Therapy

Who this might be right for
Atrial Fibrillation
Bayer 160
Not applicableStudy completedNCT04435769
What this trial is testing

Non-Interventional Study Describing Direct Costs Related to Anti-coagulation Treatment

Who this might be right for
Atrial Fibrillation
Pfizer 109
Not applicableStudy completedNCT03572972
What this trial is testing

Non-interventional, Retrospective Cohort Study to Explore OAC Treatment in Korea

Who this might be right for
Atrial Fibrillation
Pfizer 64,684
Not applicableStudy completedNCT01885598
What this trial is testing

Eliquis Regulatory Post Marketing Surveillance

Who this might be right for
NonValvular Atrial Fibrillation
Bristol-Myers Squibb 3,335
Testing effectiveness (Phase 2)Study completedNCT00645853
What this trial is testing

Long-term Safety in Atrial Fibrillation Patients

Who this might be right for
Persistent or Permanent Nonvalvular Atrial Fibrillation
AstraZeneca 523
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation